-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HxGdPB6ebEAcUlkkXxWwVYt7fQBq0vTy5jpLJaIORheeL6TyqfmxLm9BiRoJ2dGN K1PGFNwCkOCjZKW970oLIQ== 0001179110-08-004472.txt : 20080228 0001179110-08-004472.hdr.sgml : 20080228 20080228141739 ACCESSION NUMBER: 0001179110-08-004472 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080226 FILED AS OF DATE: 20080228 DATE AS OF CHANGE: 20080228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAUKIEN FRANK H CENTRAL INDEX KEY: 0001133649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 08649811 MAIL ADDRESS: STREET 1: C/O BRUKER DALTONICS CITY: BILLERICA STATE: MA ZIP: 01821 4 1 edgar.xml FORM 4 - X0202 4 2008-02-26 0 0001109354 BRUKER CORP BRKR 0001133649 LAUKIEN FRANK H C/O BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 1 1 1 0 CEO, President Common Stock 2008-02-26 4 A 0 10034387 A 29582225 D Common Stock 2008-02-26 4 A 0 755276 A 30337501 I By former spouse Common Stock 2008-02-26 4 A 0 5520187 9.14 A 35857688 D Common Stock 2008-02-26 4 A 0 296757 9.14 A 36154445 I By former spouse Acquired in exchange for 18.75% of the share capital of Bruker BioSpin Invest AG in connection with the acquisition of the Bruker BioSpin Group by BRKR. The amount in Column 5 includes 2,116,309 shares owned by Robyn Laukien over which Dr. Laukien has voting power, of which 1,052,033 shares were issued in connection with the acquisition of the Bruker BioSpin Group. Frank H. Laukien 2008-02-28 -----END PRIVACY-ENHANCED MESSAGE-----